CGTLive’s Weekly Rewind – September 2, 2022

Article

Review top news and interview highlights from the week ending September 2, 2022.

Welcome to CGTLive’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. Iovance Starts BLA Submission of Lifileucel for Advanced Melanoma

The tumor-infiltrating lymphocyte therapy has shown efficacy in the phase 2 C-144-01 trial.

2. CARsgen Advances Autologous CAR T Therapies in Multiple Myeloma, Advanced Gastric Cancer

The company has initiated the world’s first confirmatory phase 2 trial of a CAR T-cell therapy in solid tumors.

3. Mark Forman, MD, PhD, on ICM Administration of Gene Therapy in Frontotemporal Dementia

The chief medical officer of Passage Bio discussed the phase 1/2 upliFT-D study of PBFT02.

4. FDA Recognizes CRISPR Therapy for Treatment of Hereditary Angioedema

The in vivo genome-editing therapy is the first gene therapy to be evaluated in a clinical trial for preventing HAE attacks.

5. Phase 3 Heart Failure Cell Therapy Trial Receives Go-Ahead from DSMB

The risk-benefit assessment determined that there are no significant safety concerns.

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos
Jeffrey Chamberlain, PhD
Tami John, MD
Tami John, MD
Tami John, MD
Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital
Saurabh Dahiya, MD, FACP, an associate professor of medicine at Stanford University School of Medicine; as well as clinical director of Cancer Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy at Stanford Medicine
Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic
Laura Aguilar MD, PhD, the chief medical officer of Diakonos Oncology
Related Content
© 2025 MJH Life Sciences

All rights reserved.